<DOC>
	<DOCNO>NCT02854800</DOCNO>
	<brief_summary>The purpose study examine effectiveness smoke cessation intervention cigarette smoker enrol outpatient program opioid dependence . Treatment effect compare function phase outpatient program : 0-90 day , 90 days-1 year , 1 year .</brief_summary>
	<brief_title>Smoking Cessation &amp; Opioid Dependence Treatment Integration</brief_title>
	<detailed_description>Tobacco smoking rate substantially high among individual substance use disorder ( SUDs ) , relative individual general population ( e.g. , 97 % vs. 19 % , respectively ) . Yet treatment program SUDs fail address use tobacco among patient , integration smoke cessation treatment SUD treatment may improve outcome drug . The question remain , however , whether implement smoke cessation component immediately patient stabilize SUD pharmacotherapy . Existing research directly address factor limited finding mixed . Therefore , purpose study compare drug use outcome among patient three different stage SUD treatment : 0-90 day , 90 days-1 year , 1 year consistent abstinence illicit drug . Smokers currently treatment opioid dependence , WVU Comprehensive Opioid Addiction Treatment ( COAT ) program , recruit participate 12-week study . A total 20 patient complete three COAT treatment group , group match relevant demographic substance use characteristic ( e.g. , gender , number cigarette smoke per day , nicotine dependence score ) . During 12-week intervention period , individual continue attend regular COAT clinic appointment follow standard varenicline ( ChantixÂ® ) dose regimen respond question daily via text messaging ( e.g. , adherence varenicline , use tobacco , tobacco withdrawal side effect , etc. ) . The primary outcome relevant feasibility : 1 ) recruitment retention rate , 2 ) adherence medication regimen , 3 ) compliance respond text message-based question . Secondary outcome include comparison group 1 ) proportion relapse substance , 2 ) proportion smoker abstinent assessment ( confirm expire air carbon monoxide sample ) , 3 ) day successful cigarette quit day , 4 ) substance withdrawal-related symptom .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>enrol Comprehensive Opioid Addiction Treatment ( COAT ) program report smoke &gt; 10 cigarette per day &gt; 1 year provide expire air carbon monoxide ( CO ) reading &gt; 10 parts/million ( ppm ) report interest make quit attempt next 16 month ( Contemplation Preparation stag via Stage Change ; Prochaska &amp; Diclemente , 1983 current engagement form tobacco cessation ( e.g. , pharmacotherapy ) current use contraindicate medication ( e.g. , theophylline , warfarin , insulin ) Stage Change category Precontemplation ( plan quit ) , Action ( actively try quit ) , Maintenance ( already quit ) selfreported seizure past year untreated cardiovascular disease selfreport breastfeed pregnancy ( verified urinalysis ) within 4 week advance next COAT group</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>varenicline</keyword>
	<keyword>buprenorphine</keyword>
</DOC>